Fluicell
Company Details
Status: Public
Employees: 1-10
Location:
Flöjelbergsgatan 8c, Mölndal, Vastra Gotaland County 431 37, SE
Type:
sample
Technology:
sample
sample
sample
sample
About: Fluicell is transforming how we treat disease with one-of-a-kind tissue solutions for regenerative medicine and drug screening. With the groundbreaking Nexocyte platform, based on twenty years of disruptive and patent-protected R&D, we are creating new ways to target serious diseases using precision-engineered biological tissues. Our transplantable tissues have the potential to help patients living with uncurable tissue damage related to cardiac, pulmonary, metabolic, kidney and other diseases. Fluicell's first ambitious goal is to develop transplantable tissues to cure type 1 diabetes, impacting the lives of millions of patients. Nexocyte-generated tissues also enable our world-leading partners to advance their drug-screening capabilities for the development of game-changing medicines.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Fluicell | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.